It also upregulates BUB1, which activates the TGF-β/SMAD pathway, promoting EMT, and affecting glioma stem cells (GSCs) and their associated signalling, which contributes to malignant progression [40, 41]. Here, TGFB1 is linked to central nervous system cancer.